Sarcopenia and fall-related outcomes in Chinese adults aged 45 years or older: a longitudinal cohort study

中国45岁及以上成年人肌少症与跌倒相关结局:一项纵向队列研究

阅读:1

Abstract

Sarcopenia, the progressive loss of muscle mass and function, is a significant health concern in middle-aged and older adults, potentially linked to adverse outcomes like falls and fractures. A cohort study was conducted utilizing participants aged ≥ 45 years from CHARLS. Sarcopenia was defined using established criteria. Primary outcomes were isolated falls, isolated hip fractures, and composite outcomes. Associations were assessed using multivariable Cox regression (adjusted for confounders), propensity score matching (PSM), and inverse probability weighting (IPW), reporting hazard ratios (HRs) and 95% confidence intervals (CIs).Conduct sensitivity analyses such as stratification to control for confounding. Among 6,939 participants (42.6% with sarcopenia), 10-year incident rates were 39.7% for isolated falls, 3.3% for isolated hip fractures, and 1.7% for composite outcomes. Sarcopenia was persistently associated with an increased risk of isolated falls across all analyses (adjusted HR = 1.20, 95% CI:1.10–1.31, p < 0.01; PSM HR = 1.19, p < 0.01; IPW HR = 1.26, p < 0.001). For isolated hip fractures, significant associations were found in adjusted (HR = 1.60, 95% CI:1.17–2.17, p = 0.003) and IPW analyses (HR = 1.78, p = 0.01), but not PSM (HR = 0.99, 95%CI:0.68–1.44, p = 0.958). No significant association was found between sarcopenia and composite outcomes.Sensitivity analysis confirmed the robustness of the results. Sarcopenia is a significant risk factor for falls in middle-aged and older Chinese adults. Its association with hip fractures requires further investigation due to inconsistent findings across analytical methods. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1038/s41598-026-43398-8.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。